Ticker Scorecard - ADTX Basics Company: ADiTx Therapeutics, Inc. IPO Date: June 30, 2020 Sector: Healthcare Industry: Biotech Market Cap: $7.56M Activated in VL: True Average Daily Range Avg Daily Range: $0.22 | 5.84% Avg Daily Range (30 D): $0.01 | 6.77% Avg Daily Range (90 D): $0.08 | 7.83% Institutional Daily Volume Avg Daily Volume: .87M Avg Daily Volume (30 D): 27.18M Avg Daily Volume (90 D): 11M Trade Size Avg Trade Size (Sh.): 146 Avg Trade Size (Sh.) (30 D): 1,488 Avg Trade Size (Sh.) (90 D): 611 Institutional Trades Total Inst.Trades: 20 Avg Inst. Trade: $.71M Avg Inst. Trade (30 D): $.56M Avg Inst. Trade (90 D): $.56M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $.99M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: K     News Nov 6, 2024 @ 10:55 PM Appili Therapeutics Announces Results of Special M... Source: N/A Oct 10, 2024 @ 7:40 PM Appili Therapeutics – Press Release Correct... Source: N/A Apr 2, 2024 @ 5:23 PM Why Stryve Foods Shares Are Trading Lower By Aroun... Source: Avi Kapoor Jan 2, 2024 @ 6:35 PM Why Longboard Pharmaceuticals Shares Are Trading H... Source: Avi Kapoor Jan 2, 2024 @ 1:07 PM Why LumiraDx Shares Are Trading Lower By 20%; Here... Source: Avi Kapoor Financials   TTM Q1 2024 Q4 2023 Basic EPS $-30.04 $-9.14 $28.79 Diluted EPS $-30.36 $-9.21 $27.73 Revenue $ .51M $ .08M $ .08M Gross Profit $ -.14M $ .01M $ -.2M Net Income / Loss $ -84.1M $ -14.87M $ -53.8M Operating Income / Loss $ -31.82M $ -11.54M $ -7.95M Cost of Revenue $ .64M $ .07M $ .29M Net Cash Flow $ -.21M $ M $ -1.55M PE Ratio     Splits Oct 02, 2024:   40:1 Aug 18, 2023:   40:1 Sep 14, 2022:   50:1